🇺🇸 FDA
Pipeline program

IONIS DGAT2Rx

ISIS 484137-CS2

Phase 2 small_molecule completed

Quick answer

IONIS DGAT2Rx for Hepatic Steatosis is a Phase 2 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
IONIS PHARMACEUTICALS INC
Indication
Hepatic Steatosis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials